The authors present new data from the DANCER and REFLEX trials on Rituxan.
You are here
P&T® Journal contents for June 2006
Rituximab for the Treatment of Refractory Rheumatoid Arthritis: New Information from Clinical Trials
Cost Implications of Using Unfractionated Heparin or Enoxaparin in Medical Patients at Risk for Venous Thromboembolic Events
Using “real-world” data, the authors present a comparison of costs of unfractionated heparin and a low-molecular-weight heparin (enoxaparin) in preventing thromboembolism in hospitalized patients.
Dr. Goldenberg reviews rituximab (Rituxan) for rheumatoid arthritis, alglucosidase alfa (Myzozyme) for Pompe disease, and docetaxel (Taxotere) for advanced stomach cancer.
The authors review interferon beta-1b for emerging multiple sclerosis, a rotigotine patch as adjunctive therapy in Parkinson’s disease, levetiracetam for epileptic seizures, a new sumatriptan formulation and botulinum A for migraine, donepezil for severe Alzheimer’s disease, pramipexole for restless legs syndrome, atomoxetine for attention-deficit/hyperactivity disorder and comorbid Tourette syndrome, and pregabalin for pain relief.
A new book by Susan McCurry, PhD — When a Family Member Has Dementia — offers practical suggestions for caregivers of patients with Alzheimer’s disease.